{"doi":"10.1038/sj.embor.embor861","title":"MYC recruits the TIP60 histone acetyltransferase complex to chromatin","abstract":null,"journal":"The EMBO Reports","year":2003,"id":14701,"datarank":12.618232873613215,"base_score":6.0112671744041615,"endowment":6.0112671744041615,"self_citation_contribution":0.9016900761606244,"citation_network_contribution":11.71654279745259,"self_endowment_contribution":0.9016900761606244,"citer_contribution":11.71654279745259,"corpus_percentile":null,"corpus_rank":null,"citation_count":407,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":18,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":115000,"name":"Tiziana Parisi","orcid":null,"position":1,"is_corresponding":false},{"id":115001,"name":"Stefan Taubert","orcid":null,"position":2,"is_corresponding":false},{"id":115002,"name":"Paula Fernandez","orcid":null,"position":3,"is_corresponding":false},{"id":115003,"name":"Miriam Fuchs","orcid":null,"position":4,"is_corresponding":false},{"id":115004,"name":"Ho‐Man Chan","orcid":null,"position":5,"is_corresponding":false},{"id":115005,"name":"David M Livingston","orcid":null,"position":6,"is_corresponding":false},{"id":115006,"name":"Bruno Amati","orcid":null,"position":7,"is_corresponding":false},{"id":114999,"name":"Scott R Frank","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":6.0112671744041615,"endowment":6.0112671744041615,"datacite_reuse_total":18,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"12776177","pmcid":"PMC1319201","openalex_id":"https://openalex.org/W2070399051","authors":[],"funders":[],"total_grants":0,"fwci":8.0171,"citation_percentile":0.98376008,"influential_citations":23,"citation_trend":[{"year":2012,"count":15},{"year":2013,"count":14},{"year":2014,"count":24},{"year":2015,"count":18},{"year":2016,"count":10},{"year":2017,"count":16},{"year":2018,"count":11},{"year":2019,"count":14},{"year":2020,"count":13},{"year":2021,"count":42},{"year":2022,"count":18},{"year":2023,"count":16},{"year":2024,"count":9},{"year":2025,"count":8},{"year":2026,"count":3}],"oa_status":"green","license":"https://www.springer.com/tdm","oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1319201","host_type":"repository"},{"url":"https://europepmc.org/articles/pmc1319201?pdf=render","host_type":"GREEN"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1319201","host_type":"repository"},{"url":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1038%2Fsj.embor.embor861","host_type":"publisher"},{"url":"https://link.springer.com/content/pdf/10.1038/sj.embor.embor861.pdf","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/full-xml/10.1038/sj.embor.embor861","host_type":"publisher"},{"url":"https://link.springer.com/article/10.1038/sj.embor.embor861/fulltext.html","host_type":"publisher"},{"url":"https://www.embopress.org/doi/pdf/10.1038/sj.embor.embor861","host_type":"publisher"},{"url":"https://doi.org/10.1038/sj.embor.embor861","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/12776177","host_type":"repository"},{"url":"http://europepmc.org/pmc/articles/PMC1319201","host_type":"repository"}],"fields_of_study":["Genomics and Chromatin Dynamics","Chromatin Remodeling and Cancer","Ubiquitin and proteasome pathways","Biology","Medicine","Acetyltransferases","Adenoviridae","Animals","Cell Line","Chromatin","DNA","Genetic Vectors","Histone Acetyltransferases","Histones","Humans","Lysine Acetyltransferase 5","Precipitin Tests","Protein Binding","Proto-Oncogene Proteins c-myc","Rats"],"mesh_terms":["Lysine Acetyltransferase 5","Acetyltransferases","Adenoviridae","Animals","Cell Line","Chromatin","DNA","Genetic Vectors","Histones","Humans","Precipitin Tests","Protein Binding","Proto-Oncogene Proteins c-myc","Rats","Histone Acetyltransferases"],"keywords":["PCAF","Histone Acetyltransferases","Histone acetyltransferase","Chromatin","Histone","P300-CBP Transcription Factors","Histone H2A","Acetylation","Chromatin remodeling","Histone H4","Histone methyltransferase","Transcription factor","Histone code","Biology","Cancer research","Molecular biology","Cell biology","Chemistry","Genetics","DNA","Gene","Nucleosome"],"sdg_mappings":[],"linked_datasets":[{"doi":"10.6084/m9.figshare.13719315.v1","title":"Additional file 1 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.13719315","title":"Additional file 1 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.13719330","title":"Additional file 6 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719327.v1","title":"Additional file 5 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719330.v1","title":"Additional file 6 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719327","title":"Additional file 5 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719333.v1","title":"Additional file 7 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719339.v1","title":"Additional file 9 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719324","title":"Additional file 4 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719321","title":"Additional file 3 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719336","title":"Additional file 8 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719321.v1","title":"Additional file 3 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719333","title":"Additional file 7 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719336.v1","title":"Additional file 8 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719324.v1","title":"Additional file 4 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719318.v1","title":"Additional file 2 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719339","title":"Additional file 9 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.13719318","title":"Additional file 2 of Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer","publisher":"figshare","resource_type":"Image"}],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"gen"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-01T13:50:23.781754Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}